Ibaraki, Japan

Kenji Sakamoto

This inventor holds 1 USPTO granted patent. Top assignee: Tsumura Co., Ltd.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Sakamoto. Retrieved from https://idiyas.com/inventor/kenji-sakamoto-rvr1eq3o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Kenji Sakamoto

Introduction: Kenji Sakamoto, a distinguished inventor based in Ibaraki, Japan, has made significant contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, Sakamoto’s work is exemplified by his notable patent in calcitonin derivatives.

Latest Patents: Kenji Sakamoto holds one patent, which revolves around the innovative field of calcitonin derivatives. This patent showcases his expertise and commitment to advancing medical science through innovative solutions.

Career Highlights: Employed by Tsumura & Co., Sakamoto has been instrumental in pushing the boundaries of pharmacological research. His role at Tsumura & Co. has allowed him to leverage his inventiveness to create impactful products that enhance health outcomes.

Collaborations: Kenji has worked closely with notable collaborators, including Ronald C. Orlowski and Satoshi Hanamura. These partnerships reflect his dedication to teamwork and the collective effort required in the pursuit of scientific and medical advancements.

Conclusion: Kenji Sakamoto stands as a testament to the spirit of innovation in the pharmaceutical industry. With his patent on calcitonin derivatives and his collaborations at Tsumura & Co., he continues to inspire the next generation of inventors and researchers in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…